Skip to content
Abierto
Menu

Award notice

Safety Evaluation and Toxicology Studies and Related Services for Drug Development

75N95024D00019

National Institutes of Health, National Institutes of Health Nida. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

View on SAM.govMarkdown

Awarded

Sri International

$48,622,546.00 on the award notice, June 20, 2024, contract 75N95024D00019

Description

As published on SAM.gov.

This snyopsis of contract award is published pursuant to FAR Subpart 5.3.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Sri International
UEI
SRG2J1WS9X63
CAGE
03652
Vendor location
Menlo Park, CA
Contract
75N95024D00019
Obligated
$0.00, potential $48,622,546
Actions
1 between June 20, 2024 and June 20, 2024
Competition
Full and Open Competition, 6 offers received
Set-aside reported
No Set Aside Used.
Described as
Safety Evaluation and Toxicology Studies and Related Services for Drug Development
Match
award number 75N95024D00019 equals the contract number; same awarding office 75N950 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 13, 2024

    Award notice, originally solicitation

    Awarded to SRI INTERNATIONAL Menlo Park for $48,622,546. SAM.gov, notice c801402918e043d6aac9c6240b881ba1

Points of contact

Also open from this buyer